H1 2025 results now out
Read moreAlzheimer peptide vaccine: Testimonial with Tord Labuda, CEO, Alzinova AB
Learn more about the collaboration
Watch the video hereInnovation for large-scale peptide production
See our presentation at a recent broker event related to GLP-1
Download presentationCreating the future in peptides
We lead innovation in peptide API’s to the benefit of millions of patients
Contact usAhead on green peptide chemistry
Together we improve process performance while reducing the environmental footprint
Learn moreMarket leader in peptide API manufacturing and services
PolyPeptide is a Contract Development & Manufacturing Organization (CDMO) supporting pharmaceutical and biotech companies in the development and manufacturing of proprietary and generic active pharmaceutical ingredients (API).
Capacity expansion for major Pharma’s hormonal disorders and women’s health portfolio
29 Sep 2025 - We’re proud to announce a capacity expansion at our Braine-l’Alleud site in Belgium, strategically backed by customer financing. This investment underscores our commitment to capturing growth in […]
Read morePolyPeptide Group achieves significant milestone in Malmö expansion project
22 Sep 2025 - Baar, 22 September 2025 – PolyPeptide Group AG (SIX: PPGN), a specialized, global CDMO for peptide-based active pharmaceutical ingredients, today announced the successful delivery and installation […]
Read more